New blood test predicts breast cancer recurrence years in advance
Summary: A new blood test can predict breast cancer recurrence 3 years before tumors are detectable, offering hope for improved long-term treatments. The test detects circulating tumor DNA, identifying relapse on average 15 months after the test, with the longest period being 41 months. In a trial, all 11 relapsed patients were successfully identified among 78 participants, showing promising early detection potential.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings